Skip to main content
. 2021 Aug 9;7(8):e07738. doi: 10.1016/j.heliyon.2021.e07738

Table 2.

Interventional and in vivo studies evaluating the antioxidant biological activity of cocoa and its derivatives.

Substances Subjects Study type Dose Outcome Authors
Dark chocolate 20 healthy subjects Interventional 40g/day for two weeks ↑ Epicatechin levels [109]
↓ DNA damage
Dark chocolate 84 subjects with risk factors of metabolic syndrome Interventional 2g/day for 6 months ↓ Genotoxicity in buccal epithelial cells [110]
Cocoa powder 18 healthy subjects Interventional 40g/day for 1 week cocoa powder in water ↓ NFκβ activation [111]
Dark chocolate 20 healthy subjects Interventional 40g/day ↑ Serum epicatechin level [112]
20 smokers ↓ ROS production
↓ 8-iso-PGF2α and NADPH oxidase activation in smokers
Flavanol-rich cocoa 6 Healthy subjects Interventional 1–4g/day for 4 weeks cocoa ↑ Plasma epicatechin and GSH levels [113]
↓ Reduction of F2 isoprostanes levels
Modulation of PUFA metabolism
Cocoa extract 24 overweight/obese middle-aged subjects Interventional 1.4g cocoa extract/daily for 4 weeks ↑ Cocoa-derived metabolites in plasma [116]
↓ Systolic blood pressure
Cocoa powder 42 high-risk volunteers Interventional 40g/day for 4 weeks ↑ HDL [52]
↓ Oxidized LDL
Cocoa powder 100 subjects with type 2 diabetes Interventional 20g/day for 6 weeks ↓ Blood cholesterol, triglyceride, LDL [115]
↓ TNF-α, high sensitive C-reactive protein, IL-6
Inhibition of lipid peroxidation
Cocoa product rich in fiber 24 healthy subjects Interventional 30g/day cocoa product rich in fiber ↑ Serum HDL [114]
20 hypercholesterolaemic subjects ↓ Glucose, IL-1β and IL-10
Cocoa product rich in fiber 21 volunteers with moderate hypercholesterolaemia Interventional 30g/daily for 8 weeks ↓ Systolic and diastolic blood pressure [114]
↓ MDA values
Dark chocolate Sprague-dawley rats (40–60 g) in vivo 10% of bodies weight for 3 weeks ↓ COX-2 expression levels [120]
Regulation of proliferation index
↓ Lower ACF formation induced by AOM
Cocoa extract BALB/c mice in vivo 34.5 mg/kg for 2 weeks Suppression of hepatotoxicity and inflammation [119]
Early stage antifibrotic and anticarcinogenic effects
Cocoa liquor Streptozotocin (STZ)-induced diabetic rats in vivo 3.6 g/kg to 7.2 g/kg body weight by day for 40 days of cocoa liquor in water ↓ Plasma triacylglycerol levels [45]
↑ HDL and plasma antioxidant capacity
↓ Lipid peroxidation in plasma and tissues
Cocoa-rich diet Type 2 diabetic Zucker diabetic fatty rats in vivo All experimental groups were provided with food and water ad libitum Improved glucose tolerance and insulin resistance
↓ ROS levels and carbonyl content [121]
Polyphenol enriched cocoa powder Prediabetic model triggered by a sucrose rich diet in vivo 200 mg/kg body weight by day for 3 weeks ↓ Insulin resistance [122]
↓ Hepatic carbohydrate and lipid dysmetabolism
↓ Oxidative stress and inflammation
Cocoa fiber product Spontaneously hypertensive rats in vivo 200, 400, and 800 mg/kg/day by 10 weeks ↓ Systolic blood pressure [123]
↓ Glucose, cholesterol, and triglyceride levels
↓ Liver and plasma MDA levels
Cocoa-rich diet Spontaneously hypertensive rats in vivo 300 mg/kg of cocoa-rich extract ↓ Systolic blood pressure [124]
Phenolic-rich extract from Cocoa liquor Wistar rats with high-fat diet in vivo 2.1 g of liquor/kg to 7.2 g of liquor/kg body weight by day for 28 days ↓ Lipid peroxidation [77]
↑ Plasma and tissue antioxidant capacities
Cocoa powder Sprague Dawley rats with high-fat diet in vivo 52–108 days with 12.5% cocoa supplementation regimes ↓ NADPH oxidase protein levels [125]
↓ Inflammation and fibrosis
Cocoa bean extracts Wistar rats with high-fat diet in vivo 2.25–2.45% of the total diet Improvement of physiological parameters [105]
Enhancement of antioxidant status

DNA: deoxyribonucleic acid; NFκβ: nuclear factor kappa β; ROS: reactive oxygen species; 8-iso-PGF2α: 8-iso-prostaglandin F2α; NADPH: nicotinamide adenine dinucleotide phosphate; GSH: glutathione; PUFA: polyunsaturated fatty acids; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TNF-α: tumor necrosis factor alpha; IL-6: interleukin 6; IL-1β: interleukin 1β; IL-10: interleukin 10; MDA: malondialdehyde; COX-2: cyclooxygenase-2; ACF: aberrant crypt foci; AOM: azoxymethane.